Navigation Links
Burrill & Company Announces Promotions
Date:4/9/2009

SAN FRANCISCO, April 9 /PRNewswire/ -- Burrill & Company, a San Francisco based global leader in the life sciences with principal activities in Venture Capital, Private Equity, Merchant Banking and Media, is pleased to announce the following staff promotions:

Tiba Aynechi to Director, Merchant Banking

Garrett Vygantas, Director, Venture Capital

Neel Patel to Senior Associate, Merchant Banking

Tiba Aynechi joined Burrill Merchant Banking in 2006 following an internship in the Venture Group. Previously, Tiba was a postdoctoral fellow at the University of California, San Francisco, developing computational models for drug discovery. She received her Ph.D. from the Graduate Group in Biophysics at the University of California, San Francisco.

Garrett Vygantas - Before joining Burrill in 2006, Garrett was with Genentech's Market Planning Group where he focused on the commercialization and launch of Lucentis for the treatment of wet age-related macular degeneration. Dr. Vygantas completed his Transitional Residency at the University of Pennsylvania and holds M.D. and MBA degrees from Georgetown University. He is a co-founder and interim CEO of NewBridge Pharmaceuticals and serves on its Board of Directors. He is a Board Observer of Nora Therapeutics, Proventys, Ikano Therapeutics, ProteoGenix, and NanoVasc.

Neel Patel has broad advisory experience across life sciences coupled with functional experience in post-merger integration, turnaround management, operations and strategic planning. Neel was a management consultant with A.T. Kearney where he focused on strategy and operations consulting. He also worked in business development at Roche Diagnostics. He has an MBA from the University of Chicago Graduate School of Business.

"Our Merchant Banking and Venture Capital Practices continue to perform very well despite the difficult economic climate that we are currently facing. The promotions are reflective of the excellent contributions that these three individuals have made," said, G. Steven Burrill, CEO, Burrill & Company.

About Burrill & Company

Founded in 1994, Burrill & Company is a San Francisco-based global leader in life sciences with activities in Venture Capital, Private Equity, Merchant Banking and Media. The Burrill family of venture capital funds has over $950 million under management and its merchant banking business is one of the industry leaders in life sciences transactions. Burrill is also the creator, sponsor and facilitator of leading industry conferences worldwide and publisher of a range of bio-intelligence reports including the Burrill Report (www.burrillreport.com), which tracks the progress of the global biotechnology industry; the Burrill Report Weekly Brief, and annual "State of the Industry" report the latest of which is Biotech 2009-Life Sciences: Navigating the Sea Change, the 23rd report on the industry. This book contains analysis and perspectives on the performance of the industry in 2008 and projections for 2009 and beyond (www.burrillandco.com/Biotech2009)


'/>"/>
SOURCE Burrill & Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Burrill & Company Reacquires Burrill Life Sciences Media Group LLC
2. Biotech Finishes on a High in August, Burrill Report Says
3. Genomma Lab Acquires the Mexican Company Medicinas y Medicamentos Nacionales
4. New Sports Supplement Company to Partner with Indus Biotech
5. Sonic Innovations Celebrates Companys First Receiver-In-Canal Hearing Aid
6. Edmond Scientific Company Demonstrates RHIO/HIE Data Security and Privacy Solution for the NHIN at Annual HIMSS Conference, Chicago 09
7. Kashi Company Expands With New Island Vanilla(TM) Biscuit Cereal
8. TrinityCare Senior Living, Inc. Retains RJ Falkner & Company, Inc. as Investor Relations Counsel
9. Alivemax -- A Company Releasing Supplemental Products That Will Uplift the Health, Appearance, and Confidence of Others Around the Globe
10. Carriage Services Updates Company & Investment Profile
11. Anthem Blue Cross and Blue Shield, Eli Lilly and Company Establish Coalition to Help Improve the Health of Indiana Residents with Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... (PRWEB) , ... December 06, 2016 , ... It can ... holiday presents for their four-legged family members as they do for their human friends ... pet parents’ desire to find the highest quality and most innovative pet products has ...
(Date:12/6/2016)... GA (PRWEB) , ... December 06, 2016 , ... ... and the impact of new federal healthcare regulations at the 7th annual Health ... Centre, Atlanta. , Andy Slavitt, acting administrator for the Centers for Medicare & ...
(Date:12/6/2016)... ... 2016 , ... The V Foundation for Cancer Research, a ... to Lose fundraising campaign. As the V Foundation’s boldest initiative to date, Not ... The campaign aims to raise $200 million by 2020 and strategically fund emerging, ...
(Date:12/6/2016)... ... 2016 , ... Just in time for the holiday season, the celebrated paleo ... for Honeyville’s new Organic Quinoa Flour product for sale at Costco stores throughout the ... , “I think it’s wonderful that a growing number of retailers such as ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... Friday, November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This ... label design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... 5, 2016 Spain Glaucoma Surgery Devices Market ... "Spain Glaucoma Surgery Devices Market Outlook to 2022", provides ... market. The report provides value, in millions of US ... market segements - Canaloplasty Micro Catheters and Glaucoma Drainage ... distribution shares data for each of these market segements, ...
(Date:12/5/2016)... , Dec. 5, 2016  Cornerstone Pharmaceuticals, Inc., ... presented data from two Phase I trials evaluating ... the 58th annual meeting of the American Society ... California . The two datasets show encouraging ... myeloid leukemia (AML) and T-cell non-Hodgkin,s lymphoma (T-cell ...
(Date:12/5/2016)... YORK, Pa. , Dec. 5, 2016  Pennsylvania ... of Drug and Alcohol Programs Gary Tennis ... reversal drug, at Minnich,s Pharmacy in York ... standing order signed by Dr. Levine as a prescription ... "It,s important to remember that any ...
Breaking Medicine Technology: